These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11055622)

  • 1. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
    Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
    Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating estrogen metabolites and risk for breast cancer in premenopausal women.
    Arslan AA; Shore RE; Afanasyeva Y; Koenig KL; Toniolo P; Zeleniuch-Jacquotte A
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2273-9. PubMed ID: 19661086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
    Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
    Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen metabolites and the risk of breast cancer in older women.
    Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
    Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States).
    Bentz AT; Schneider CM; Westerlind KC
    Cancer Causes Control; 2005 May; 16(4):455-61. PubMed ID: 15953988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic studies of estrogen metabolism and breast cancer.
    Ziegler RG; Fuhrman BJ; Moore SC; Matthews CE
    Steroids; 2015 Jul; 99(Pt A):67-75. PubMed ID: 25725255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
    Ruan X; Seeger H; Wallwiener D; Huober J; Mueck AO
    Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen metabolism and risk of breast cancer in postmenopausal women.
    Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
    J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.
    Arslan AA; Koenig KL; Lenner P; Afanasyeva Y; Shore RE; Chen Y; Lundin E; Toniolo P; Hallmans G; Zeleniuch-Jacquotte A
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1290-7. PubMed ID: 24769889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.
    Ziegler RG; Rossi SC; Fears TR; Bradlow HL; Adlercreutz H; Sepkovic D; Kiuru P; Wahala K; Vaught JB; Donaldson JL; Falk RT; Fillmore CM; Siiteri PK; Hoover RN; Gail MH
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):607-14. PubMed ID: 9168003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
    Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
    Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones.
    Lu LJ; Cree M; Josyula S; Nagamani M; Grady JJ; Anderson KE
    Cancer Res; 2000 Mar; 60(5):1299-305. PubMed ID: 10728690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2-/16α-Hydroxylated Estrogen Ratio-Breast Cancer Risk Hypothesis: Insufficient Evidence for its Support.
    Stanczyk FZ
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105685. PubMed ID: 32320758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary estrogen metabolites and breast cancer: a case-control study.
    Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.
    Riza E; dos Santos Silva I; De Stavola B; Bradlow HL; Sepkovic DW; Linos D; Linos A
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):627-34. PubMed ID: 11401912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense
    Green T; See J; Schauch M; Reil J; Glover M; Brix J; Gerry A; Li K; Newman M; Gahler RJ; Wood S
    J Complement Integr Med; 2023 Mar; 20(1):199-206. PubMed ID: 36201753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection.
    Fowke JH; Qi D; Bradlow HL; Shu XO; Gao YT; Cheng JR; Jin F; Zheng W
    Steroids; 2003 Jan; 68(1):65-72. PubMed ID: 12475724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen metabolism and breast cancer.
    Kabat GC; O'Leary ES; Gammon MD; Sepkovic DW; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Bradlow HL
    Epidemiology; 2006 Jan; 17(1):80-8. PubMed ID: 16357599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.